 |
|
Clinical impact of five cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease (MASLD): Insights into regional and ethnic differences
Joo Hyun Oh, Dae Won Jun
Clin Mol Hepatol. 2024;30(2):168-170. Published online 2024 Mar 5 DOI: https://doi.org/10.3350/cmh.2024.0140
|
|
Citations to this article as recorded by
 Correspondence on Letter regarding “Prognosis of biopsy-confirmed MASLD: A sub-analysis of the CLIONE study”
Hideki Fujii, Michihiro Iwaki, Yoshihiro Kamada
Clinical and Molecular Hepatology.2024; 30(2): 281. CrossRef
|